Stock Comparison

JNJ vs SENS

Johnson & Johnson vs Senseonics Holdings Inc

The Verdict

SENS takes this one.

JNJ

Johnson & Johnson

1.0

out of 10

Distressed

Winner

SENS

Senseonics Holdings Inc

6.6

out of 10

Solid Pick

Head-to-Head

$557.1B

Market Cap

$383M

26.5

P/E Ratio

-3.3

21.8%

Profit Margin

-214.2%

26.3%

Return on Equity

-130.0%

0.6

Debt-to-Equity

0.6

Conservative

Overall Risk

Aggressive

1.0

DVR Score

6.6

The Deep Dive

JNJ1.0/10

Johnson & Johnson (JNJ) continues to demonstrate robust financial performance, with Q1 2026 results exceeding consensus on both revenue and adjusted EPS, reflecting nearly 10% YoY revenue growth. Its diversified healthcare portfolio provides significant market leadership and a wide economic moat, indicating stability and consistent profitability. However, its massive market capitalization of $555....

Full JNJ Analysis

SENS6.6/10

Senseonics (SENS) demonstrates strong operational execution with 87% YoY revenue growth in Q1 2026 and a strategic shift to direct European sales, strengthening its long-term competitive position. The unique 1-year Eversense sensor offers a significant market opportunity in the CGM space. However, the company continues to incur substantial net losses ($32.3M in Q1) and heavy cash burn. While recen...

Full SENS Analysis

Want More Comparisons?

Run any stock through our deep value analyzer.

Analyze Any Stock →

Not Financial Advice

This comparison is for educational purposes only. We are not financial advisors. Always do your own research and consult a qualified advisor before investing.